Research Projects & Grants

For Profit Organization

  • Evaluation of patient outcomes from the kidney allograft outcomes allosure registry (KOAR), Role: Investigator, CareDx, Inc., (10/2023 - 10/2024) Status: Approved
  • A phase 3 prospective, randomized, multi-center, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-matched, living donor kidney transplants, Role: Investigator, Medeor Therapeutics, Inc., (05/2023 - 05/2024) Status: Approved

Internal

  • Highly Suppressive Regulatory T Cell as a Biomarker for Immunologically Relevant Delayed/Slow Graft Function after Kidney Transplantation, Role: Investigator, LLU Dept. of Surgery, (10/2020) Status: Approved
  • Transplantation of HCV positive donor kidneys in HCV negative or previously successfully treated recipients, Role: Investigator, LLU Transplantation Institute, (12/2023 - 12/2024) Status: Approved

Non-Profit Organization

  • Integration of donor-derived cell-free DNA with HLA-DR+TNFR2+ regulatory T cell in the prediction of acute rejection and graft function after kidney transplantation, Role: Investigator, American Society of Transplant Surgeons, (08/2023 - 08/2024) Status: Approved